London, UK / Amsterdam, The Netherlands / New York, US — 17 November 2025
Radcliffe Group today announced a significant step in its global expansion with the establishment of Radcliffe Medical Education (RME) B.V. in the Netherlands — its new global medical education fiscal office — and Radcliffe Medical Education LLC in the United States. These moves represent an important milestone in the organisation's ambition to strengthen its international presence and enhance its ability to support the global healthcare community.
The decision to expand into both regions reflects the rapid growth of Radcliffe's client base and the increasing demand for high-quality, independent medical education across Europe, North America and worldwide. Relocating its primary medical education operations to the Netherlands positions Radcliffe to work more closely with EU-based pharmaceutical and MedTech partners, providing seamless access to the EU single market for IME/CME collaborations, contracting, grant funding, regulatory compliance and talent recruitment.
Strategic European Hub in the Netherlands
The Netherlands provides a strategic hub for European operations, benefiting from world-class life-science institutions, leading medical research centres and exceptional transport access to major global congresses. Relocating its primary medical education operations to the Netherlands positions Radcliffe to work more closely with EU-based pharmaceutical and MedTech partners. Key advantages of the new European base include:
- Seamless access to the EU single market for IME/CME collaboration and contracting
- Streamlined grant funding and regulatory compliance across European markets
- Enhanced talent recruitment from world-class European life-science institutions
- Closer partnerships with EU-based pharmaceutical and MedTech organisations
- Expanded educational programmes at major US and European congresses
Expanding into the United States
Simultaneously, the launch of RME LLC in the United States strengthens Radcliffe's capacity to partner with leading American medical societies, academic institutions and industry organisations, supporting the company's expanding educational programmes at major US congresses and its commitment to delivering locally relevant, globally accessible scientific learning.
The United States remains the largest and most influential market for medical education and scientific innovation, and Radcliffe's expanded presence there enables deeper engagement with clinical experts and commercial partners across cardiovascular and related disciplines.
This dual expansion reflects the increasing demand for international collaboration in medical education and positions Radcliffe to better support clinicians, industry partners and academic stakeholders around the world.
Global Reach and Impact
This expansion marks a transformational moment for Radcliffe Group, building the infrastructure necessary to better support clinicians, industry partners and academic stakeholders around the world:
20+
Cardiovascular Platforms
500K+
Healthcare Professionals
40+
Countries Reached
Leadership Perspective
This dual expansion into the Netherlands and the United States represents a transformational moment for Radcliffe. As demand for international collaboration in medical education accelerates, we are building the infrastructure necessary to better support clinicians, industry partners and academic stakeholders around the world. These new entities allow us to work more effectively across key markets and help improve patient outcomes by advancing scientific knowledge and professional learning.
What This Means for Partners and Stakeholders
The new entities allow Radcliffe to work more effectively across key markets and help improve patient outcomes by advancing scientific knowledge and professional learning. Partners and stakeholders can expect enhanced collaboration and service delivery through the expanded international presence.
The US expansion in particular enables:
- ✓Deeper engagement with leading American medical societies and academic institutions
- ✓Locally relevant, globally accessible scientific learning programmes
- ✓Expanded presence at major US congresses and cardiovascular conferences
- ✓Strengthened partnerships with industry organisations across related disciplines
- ✓A phased operational transition ensuring continuity for all existing partners
The organisation will implement a phased operational transition while maintaining its UK footprint and ensuring continuity of service for all existing partners.
A Transformational Moment for Medical Education
The Netherlands provides a strategic hub for European operations, benefitting from world-class life-science institutions, leading medical research centres and exceptional transport access to major global congresses. Combined with the US presence, Radcliffe is now positioned to deliver truly global medical education at scale.
The United States remains the largest and most influential market for medical education and scientific innovation, and Radcliffe's expanded presence there enables deeper engagement with clinical experts and commercial partners across cardiovascular and related disciplines. Together, these two new offices represent a fundamental shift in how Radcliffe delivers independent medical education on the world stage.
As demand for international collaboration in medical education accelerates, Radcliffe Group is building the infrastructure necessary to better support clinicians, industry partners and academic stakeholders around the world — helping improve patient outcomes by advancing scientific knowledge and professional learning across borders.
About Radcliffe Group
Radcliffe Group is a leading provider of cardiovascular medical education, offering publishing, virtual events, and digital learning platforms. With decades of experience and a commitment to advancing healthcare professional development, we help medical communities access world-class educational resources.